Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$172,052,970
-$13,456,583 QoQ
Shares Held
1,361,825
+2.3% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#95
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2020CallValue
$137,782
CallShares
1,843
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $5,124,714,999 across 15 Drug Manufacturers - General names. GILD ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,697,061 | $2,035,506,044 | |
| 2 | JNJ |
Johnson & Johnson
|
4,126,113 | $1,047,908,917 | |
| 3 | AZN |
Astrazeneca PLC
|
2,746,590 | $520,808,395 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,533,955 | $454,113,217 | |
| 5 | ABBV |
AbbVie Inc.
|
1,279,175 | $321,891,596 | |
| 6 | PFE |
Pfizer Inc
|
10,281,652 | $247,582,179 | |
| 7 | AMGN |
Amgen Inc
|
646,798 | $234,218,491 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,361,825 | $172,052,970 |
All Filings in GILD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,052,970 | 1,361,825 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $185,509,553 | 1,331,058 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $166,858,156 | 1,359,444 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $175,762,173 | 1,583,443 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $203,561,754 | 1,836,040 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $99,277,196 | 886,008 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $28,246,376 | 305,796 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $19,117,447 | 228,023 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $16,445,679 | 239,698 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $70,663,029 | 964,683 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $450,745,147 | 5,564,068 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $251,073,655 | 3,350,329 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $240,298,093 | 3,117,920 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $233,076,668 | 2,809,168 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $18,676,065 | 217,543 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,086,309 | 179,710 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $20,827,867 | 336,966 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $97,926,812 | 1,647,213 | Shares | Defined | 2022-05-23 | |
| 2021-12-31 | $17,653,305 | 243,125 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $13,180,414 | 188,696 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,445,067 | 180,730 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,926,153 | 169,057 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $89,233,287 | 1,531,639 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $88,310,867 | 1,397,545 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $105,096,038 | 1,365,948 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $137,782 | 1,843 | Call | Defined | 2020-05-14 | |
| 2020-03-31 | $92,147,456 | 1,232,577 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||